Bortezomib and Celecoxib in Treating Patients With Advanced Solid Tumors

Clinical trial NCT00290680 · COMPLETED

Trial details

NCT number: NCT00290680
Sponsor: Medical University of South Carolina
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2005-03-01
Primary completion: 2009-01-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.